mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.089 |
0.1 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.1 |